Abstract

Enterococcus faecalis is part of the commensal microbiota of humans and its main habitat is the gastrointestinal tract. Although harmless in healthy individuals, E. faecalis has emerged as a major cause of nosocomial infections. In order to better understand the transformation of a harmless commensal into a life-threatening pathogen, we developed a Recombination-based In Vivo Expression Technology for E. faecalis. Two R-IVET systems with different levels of sensitivity have been constructed in a E. faecalis V583 derivative strain and tested in the insect model Galleria mellonella, during growth in urine, in a mouse bacteremia and in a mouse peritonitis model. Our combined results led to the identification of 81 in vivo activated genes. Among them, the ef_3196/7 operon was shown to be strongly induced in the insect host model. Deletion of this operonic structure demonstrated that this two-component system was essential to the E. faecalis pathogenic potential in Galleria. Gene ef_0377, induced in insect and mammalian models, has also been further analyzed and it has been demonstrated that this ankyrin-encoding gene was also involved in E. faecalis virulence. Thus these R-IVET screenings led to the identification of new E. faecalis factors implied in in vivo persistence and pathogenic potential of this opportunistic pathogen.

Highlights

  • Enterococcus faecalis is a ubiquitous lactic acid bacterium and a core constituent of the intestinal flora of humans and many animals

  • We describe the construction of a novel R-In Vivo expression technologies (IVET) promoter-trap strategy and its application to the Enterococcus faecalis V19 strain, a plasmid-cured derivative of the clinical isolate V583

  • Construction of a R-IVET system in E. faecalis In order to identify bacterial genes that are induced during the persistence of E. faecalis in an animal host, a R-IVET strategy has been performed

Read more

Summary

Introduction

Enterococcus faecalis is a ubiquitous lactic acid bacterium and a core constituent of the intestinal flora of humans and many animals. Plasmid pCre2 derivatives containing a putative in vivo induced promoter were extracted from resolved EmS and TetR cells before being introduced into the unresolved EmR and TetS Lox2DG or Lox2 strains.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.